FDA Investigator Barbara Jwilimczyk Macri

Barbara Jwilimczyk Macri has conducted inspections on 86 sites in 7 countries as of 08 Feb 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
86
Last Inspection Date:
08 Feb 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Poland, Ireland, France, Italy, Switzerland, Croatia
FDA Investigators that have inspected at least one site in common with Barbara Jwilimczyk Macri:
Addam S Reynolds, Adetutu M Gidado, Alice S Tsao, Amy L Singer, Amy M Codella, Amy M Cramer, Ankur C Patel, Ann Marie Montemurro, Anna M Brannen, Annemarie B Randow, Annemarie Bodnar, Annet R Rajan, Anthony Abel, Anthony J Donato, Ashar P Parikh, Atul J Agrawal, Azeezat M Lawal, Barbara J Maulfair, Barbara J Rincon, Byungja E Marciante, Cary Greene, CDR Ileana Barreto Pettit, Charles J Chacko, Cheryl A Clausen, Chiang Syin, PhD, Christian F Gomez Lugo, Christina K Theodorou, Christine M Cerenzio, Craig W Swanson, Daniel J Grabicki, Daniel J Min, Daniel L Zheng, Daniel W Cline, David A Oluwo, David H Smith, Dawn L Wydner, Deborah B Nixon, Denise M Visco, Investigator, Dennis Cantellops Paite, Devaughn Edwards, Devon Jenkins, Deyaa Shaheen, Dhaval H Patel, Dorothy J Denes, Douglas A Campbell, Douglas C Kovacs, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Edward O'shaughnessy, Elaine E Gilfillan, Emest F Bizjak, Emmanuel Jramos Maldonado, Eric J Cunningham, Eric Rothschild, Erin D Mccaffery, Esteban Beltran, Farhana Khan, Frank J Marciniak, Fred Razzaghi, Frederick F Razzaghi, George J Flynn, George Pyramides, Gianine E Tompkins, Gobiga Vanniyasingam, Guerlain Ulysse, Helen B Ricalde, Helen Verdel, Himanshu Gupta, PhD, Jacob G Lutz, James A Liubicich, James C Maclaughlin, James R Birkenstamm, Janet A Rajan, Janet L Bowen, Jean M Kelahan, Jeffrey J Ebersole, Jennifer A Bazergui, Jennifer D Hollstrom, Jennifer Macmillan, Jessica M Monteiro, Jill Mielziner, Joey V Quitania, Jogy George, Jonathan G Matrisciano, Joohi Castelvetere, Jose A Lopez, Jose Acruz Gonzalez, Jose M Cayuela, Joseph F Mcginnis, RPh, Joy Rkozlowski Klena, Juanita P Versace, Junho Pak, Justine Tomasso, Karen E D'orazio, Karen F Tomaziefski, Karishma G Gopaul, Keith M Reilly, Kelli F Dobilas, Kelli Regente, Kelly Doremus, Kelly I Anderson, Kerry A Kurdilla, Kim Lthomas Cruse, Kinh Q Mac, Ko U Min, Kristen E Rescigno, Kristina L Conroy, Kristy A Zielny, Krystal O Ogunremi, Krystyna M Kitson, Kyle D Covill, Lata C Mathew, PhD, Laura Fontan, MS, Lauren L Vajo, Lawrence R Johnson, Leanna M Slarsky, Li Li, Liatte Kreuger, PharmD, Lisa M Bellows, Lisa M Feola, Loretta Nemchik, Lori M Newman, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marea K Harmon, Margaret M Sands, Maria A Bienkowski, Maria A Reed, Maria Estrella, Marie B Buen Bigornia, Marjorie D Schultz, Matthew A Spataro, Matthew B Casale, Mayar M Mussa, Melba Trivera Clavell, Melissa B Libby, Melissa T Roy, Meredith L Sheridan, Michael A Charles, Michael Gurbarg, Michael R Klapal, Michael Rosner, Michael Serrano, Michele L Obert, Michele Perry Williams, Miguel A Martinez Perez, Mina D Ahmadi, Mindy M Chou, Monika Borkowska, Mra Greenc, Mra Mcculloughj, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Natasha Gupta, Nerizza B Guerin, Nicholas A Violand, Niketa Patel, Nina Yang, Odera I Ekwunife, Parul M Patel, Patrice S Hall, Patricia H Dlugosz, Patrick C Klotzbuecher, Paul L Bellamy, Paul Mouris, Paula J Bretz, Peter R Lenahan, Philip F Istafanos, DMV, MS, Pratibha Bhat, Puspa Suresh Jayasekara, Raymond L Cheung, Regina T Brown, Richard D Manney, Richard E Needham, Robert D Tollefsen, Robin P Mathew, Rochelle L Cross, Rodrigo Vilchez, Rosario D'costa, Rose Ljean Mary, Rose Xu, Russell J Glapion, Sachinkumar V Patel, Saleem A Akhtar, Sandra A Boyd, Sarah Adella Fave, Sarah Forney, Sayyem H Akbar, Schultz, Sean G Casey, Sean R Marcsisin, Sena G Dissmeyer, Sherri J Liu, Shirley S Wen, Sinai I Davis, Srinivas R Chennamaneni, PhD, Stelios C Tsinontides, Stephanie Mangigian, MS/OSH, RN, Stephanie T Durso, Stephen J Koniers, Stephen J Mottola, Suchan Kim, Susan M Halsted, Susan T Hadman, Tajah L Blackburn, Tamil Arasu, PhD, Tanya R Syffrard, Tara G Bizjak, Tara R Gooen, Terri L Dodds, Thomas E Friel, Tiffani D Wilson, Tonia F Bernard, Tonya R Johnson, Toyin B Oladimeji, Tressa T Lewis, Tyanna N Hadley, Unnee Ranjan, Valerie C Reed, Victoria Spivak, Viviana Matta, Wayne J Meyer, William R Chang, Xiaohan Cai, PhD, Xiaoping Guan, Ying Zhang, Yoriann M Cabrera Bartolomei, Yuesheng Ye, Yvesna C Blaise, Yvins Dezan, Zachary L Miller, Zakaria I Ganiyu, Zhongren Wu

Barbara Jwilimczyk Macri's Documents

Publish Date Document Type Title
May, 2015 FDA 483 Liberty Drug & Surgical - Form 483, 2015-05-22
January, 2014 FDA 483 Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc. - Form 483, 2014-01-08
September, 2016 FDA 483 Pliva Hrvatska d.o.o. - Form 483, 2016-09-20
March, 2014 FDA 483 Sonar Products, Inc. - Form 483, 2014-03-18
January, 2014 EIR Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc. - EIR, 2014-01-08
December, 2012 FDA 483 Cosmax Usa, Corporation - Form 483, 2012-12-13
June, 2010 FDA 483 Rutherford Chemicals, LLC - Form 483, 2010-06-04
June, 2011 FDA 483 Biochem Laboratory, Inc - Form 483, 2011-06-15
January, 2012 FDA 483 Actavis Elizabeth LLC - Form 483, 2012-01-13
March, 2014 FDA 483 Response Sonar Products, Inc. - Form 483R, 2014-04-03
August, 2010 FDA 483 Loricon Testing Service, Inc. - Form 483, 2010-08-12
March, 2015 FDA 483 Response Kobo Products, Inc - Form 483R, 2015-04-03
March, 2015 EIR Kobo Products, Inc - EIR, 2015-03-13
May, 2014 FDA 483 Akorn Operating Company LLC (dba Akorn) - Form 483, 2014-05-29
July, 2009 FDA 483 Ingenus Pharmaceuticals NJ LLC - Form 483, 2009-07-07
November, 2010 FDA 483 H & P Industries, Inc. - Form 483, 2010-11-10
June, 2013 EIR Hikma Pharmaceuticals USA Inc. - EIR, 2013-06-14
October, 2015 EIR Appco Pharma LLC - EIR, 2015-10-06
August, 2011 FDA 483 Vitaquest International LLC d/b/a State Nutritionals, Inc. - Form 483, 2011-08-31
August, 2015 EIR Alcami Corporation - EIR, 2015-08-26
October, 2016 FDA 483 Response RARITAN PHARMACEUTICALS INCORPORATED - Form 483R, 2016-11-03
August, 2015 FDA 483 Alcami Corporation - Form 483, 2015-08-26
April, 2013 FDA 483 Med Prep Consulting, Inc. - Form 483, 2013-04-03
October, 2013 FDA 483 Hikma Pharmaceuticals USA Inc. - Form 483, 2013-10-22
March, 2015 FDA 483 Kobo Products, Inc - Form 483, 2015-03-13
January, 2012 EIR Actavis Elizabeth LLC - EIR, 2012-01-13
October, 2011 EIR Vantage Specialty Ingredients, Inc - EIR, 2011-10-11
May, 2010 FDA 483 Cosette Pharmaceuticals, Inc. - Form 483, 2010-05-17
October, 2011 FDA 483 Vantage Specialty Ingredients, Inc - Form 483, 2011-10-11
April, 2016 FDA 483 Akorn Operating Company LLC (dba Akorn) - Form 483, 2016-04-04
October, 2013 EIR Hikma Pharmaceuticals USA Inc. - EIR, 2013-10-22
September, 2013 FDA 483 Patheon Biologics (NJ) LLC - Form 483, 2013-09-26
August, 2013 FDA 483 Novel Laboratories, Inc. - Form 483, 2013-09-11
May, 2012 FDA 483 Excelsior Medical LLC - Form 483, 2012-05-14
October, 2009 EIR Akorn Operating Company LLC (dba Akorn) - EIR, 2009-10-06
November, 2011 FDA 483 Medicia Holdings LLC - Form 483, 2011-11-04
March, 2023 FDA 483 SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - Form 483, 2023-03-24
February, 2013 FDA 483 Wedgewood Village Pharmacy, LLC - Form 483, 2013-02-11
April, 2016 FDA 483 Response Akorn Operating Company LLC (dba Akorn) - Form 483R, 2016-04-26
October, 2015 FDA 483 ACINO PRODUCTS LIMITED LIABILITY COMPANY - Form 483, 2015-10-26
October, 2016 FDA 483 RARITAN PHARMACEUTICALS INCORPORATED - Form 483, 2016-10-20
December, 2013 FDA 483 CMIC CMO USA CORP - Form 483, 2013-12-04
March, 2011 FDA 483 June Jacobs Labs, LLC - Form 483, 2011-03-21
July, 2015 FDA 483 Hikma Injectables USA Inc. - Form 483, 2015-07-13
July, 2012 FDA 483 Integra LifeSciences Corporation - Form 483, 2012-07-30
October, 2015 FDA 483 Response ACINO PRODUCTS LIMITED LIABILITY COMPANY - Form 483R, 2015-10-26
October, 2015 FDA 483 Appco Pharma LLC - Form 483, 2015-10-06
December, 2010 FDA 483 Sunrise Pharmaceutical Inc - Form 483, 2010-12-20
April, 2010 FDA 483 Vantage Specialty Ingredients, Inc - Form 483, 2010-04-08
December, 2013 EIR CMIC CMO USA CORP - EIR, 2013-12-04
May, 2016 FDA 483 Hikma Injectables USA Inc. - Form 483, 2016-05-26
June, 2010 FDA 483 Packaging Systems, LLC - Form 483, 2010-06-23
September, 2010 FDA 483 Kobo Products, Inc - Form 483, 2010-09-30

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more